Pharmacological mechanisms of black cohosh in Sprague-Dawley rats

Fitoterapia

Volumn 83, Issue 3, 2012, Pages 461-468

  Einbond, Linda Saxe ^a   Soffritti, Morando ^b   Esposti, Davide Degli ^b   Wu, Hsan Au ^a   Tibaldi, Eva ^b   Lauriola, Michelina ^b   He, Kan ^c   Park, Taesik ^a   Su, Tao ^a   Huggins, Lesley ^a   Wang, Xiaomei ^a   Roller, Marc ^c   Brennan, Richard ^d  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Ramazzini Institute   (Italy)

^c Naturex   (United States)

^d Entelos Inc   (United States)

Author keywords

Actein; Free fatty acid; Microarray; Phospholipase C; Triglyceride; Triterpene glycoside

Indexed keywords

BENZODIAZEPINE RECEPTOR; CALGRANULIN A; CARRIER PROTEINS AND BINDING PROTEINS; CASPASE 9; CIMICIFUGA RACEMOSA EXTRACT; CYCLIN D1; CYTOCHROME C; F BOX PROTEIN; FATTY ACID; GALACTOSE TRANSPORTER; GLYCOSIDE; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 5; INHIBITOR OF DIFFERENTIATION 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PHOSPHOLIPID; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN BAX; PROTEIN BIRC6; PROTEIN LIN7A; PROTEIN P53; PROTEIN PPP3CB; SOMATOMEDIN BINDING PROTEIN 3; SPHINGOSINE; TRIACYLGLYCEROL; TRITERPENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL STRAIN HEPG2; CIMICIFUGA RACEMOSA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIPID ANALYSIS; MAXIMUM TOLERATED DOSE; MICROARRAY ANALYSIS; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL PROLIFERATION; CIMICIFUGA; CYCLIN D; FATTY ACIDS; FEMALE; GENE EXPRESSION; GLYCOSIDES; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASES; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPHINGOSINE; TRIGLYCERIDES; TRITERPENES; TUBULIN; TUMOR SUPPRESSOR PROTEIN P53; TYPE C PHOSPHOLIPASES; UP-REGULATION; VINCA;

ANIMALIA; CIMICIFUGA DAHURICA; RATTUS; VINCA;

EID: 84862813807     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2011.12.011     Document Type: Article

References (22)

1. J.M. Betz, L. Anderson, M.I. Avigan, J. Barnes, N.R. Farnsworth, and B. Gerdén Black cohosh: considerations of safety and benefit Nutrition Today 44 2009 155 162
2. L.S. Einbond Black cohosh: chemopreventive and anticancer potential R.R. Watson, Complementary and Alternative Therapies and the Aging Population: An Evidence-Based Approach 2009 Elsevier Academic Press San Diego 193 227
3. L.S. Einbond, Y. Wen-Cai, K. He, H. Wu, E. Cruz, and M. Roller Growth inhibitory activity of extracts and compounds from Cimicifuga species on human breast cancer cells Phytomedicine 15 2008 504
4. D. Seidlova-Wuttke, P. Thelen, and W. Wuttke Inhibitory effects of a black cohosh (Cimicifuga racemosa) extract on prostate cancer Planta Med 72 2006 521 526
5. N. Sakurai, M. Kozuka, H. Tokuda, T. Mukainaka, E. Enjo, and M. Nishino Cancer preventive agents. Part 1: chemopreventive potential of cimigenol, cimigenol-3,15-dione, and related compounds Bioorg Med Chem 13 2005 1403 1408
6. L.S. Einbond, T. Su, H.A. Wu, H.R. Friedman, X. Wang, and B. Jiang Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth Anticancer Res 27 2007 697 712
7. L.S. Einbond, T. Su, W.A. Wu, R. Friedman, X. Wang, and A. Ramirez The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathways Int J Cancer 121 2007 2073 2083
8. L.S. Einbond, M. Soffritti, D.D. Esposti, T. Park, E. Cruz, and T. Su Activates stress- and statin-associated responses and is bioavailable in Sprague-Dawley rats Fundam Clin Pharmacol 23 2009 311 321
9. R.B. van Breemen, W. Liang, S. Banuvar, L.P. Shulman, Y. Pang, and Y. Tao Pharmacokinetics of 23-Epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh Pharmacol Ther 87 2010 219 225
10. Decreto Legislativo 116 Attuazione della direttiva n. 86/609/ CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian] Suppl Ordinario Gazz Ufficiale 40 1992 5 25
11. G.K. Smyth, J. Michaud, and H.S. Scott Use of within-array replicate spots for assessing differential expression in microarray experiments Bioinformatics 21 2005 2067 2075
12. J. Freudenstein, C. Dasenbrock, and T. Niblein Lack of promotion of Estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract Cancer Res 62 2002 3448 3452
13. L. Spangler, K.M. Newton, L.C. Grothaus, S.D. Reed, K. Ehrlich, and A.Z. La Croix The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin Maturitas 57 2007 195 204
14. W. Wuttke, C. Gorkow, and D. Seidlova-Wuttke Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study Menopause 2006 185 196
15. E. Liske Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders Adv Ther 15 1998 45 53
16. B.J. Gurley, S.F. Gardner, M.A. Hubbard, D.K. Williams, W.B. Gentry, and I.A. Khan In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes Clin Pharmacol Ther 77 2005 415 426
17. S. Tsukamoto, M. Aburatani, and T. Ohta Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa) Evid Based Complement Alternat Med 2 2005 223 226
18. Y. Huang, B. Jiang, P. Nuntanakorn, E.J. Kennelly, S. Shord, and T.O. Lawal Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro Curr Drug Saf 5 2010 118 124
19. B. Ganter, S. Tugendreich, C.I. Pearson, E. Ayanoglu, S. Baumhueter, and K.A. Bostian Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action J Biotechnol 119 2005 219 244
20. K. Brinkman, J.A. Smeitink, J.A. Romijn, and P. Reiss Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy Lancet 354 1999 1112 1115
21. S. Lüde, M. Török, S. Dieterle, A.C. Knapp, R. Kaeufeler, and R. Jäggi Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro Cell Mol Life Sci 64 2007 2848 2857
22. M. Garcia-Frenandez, H. Kissel, S. Brown, T. Gorenc, A.J. Schile, and S. Rafii Sept4/ARTS is required for stem cell apoptosis and tumor suppression Genes Dev 24 2010 2282 2293